Apteka Centrum Ejsp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-06-19
Share capital
5 000,00 PLN
Registered address
ul. Chomiczewskiego 23, 21-300 Radzyń Podlaski, Poland

Financials

Revenue history (in k)

Filing timeliness

Financial statements were filed on time, on average 56 days early.

  • 202510/06/2026
  • 202411/06/2025
  • 202317/05/2024
  • 202228/05/2023
  • 202108/06/2022
  • 202015/06/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 1.46mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 20.70kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 1.44mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 263.47kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Apteka Centrum Ej has been an NFZ healthcare provider since 2026. In 2026 it is performing 1 contract worth USD 0.00.

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmacieslubelskie1USD 0.00

Authorized Representatives

Ewa Jędrys – President of the Management Board

Manner of representation

1. In the case of a multi-member management board, the joint action of two members of the management board is required. 2. In the case of a one-person management board, the sole member of the management board is authorised to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Ewa Jędrysage 56
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-06-24.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $51,665.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$45,900
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,794
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,007

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Fragalsp. z o.o.
Modrzewscysp. j.
Pikadasp. z o.o.
Vitasp. z o.o.
Gold Lionsp. z o.o.
Grupa Aptekarska Kujałowiczsp. j.
Herbarium Świętego Franciszkasp. z o.o.
Eurekasp. z o.o.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.

FAQ

Last updated: 2026-10-07